Eucrates Biomedical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EUCR and buy or sell other stocks, ETFs, and their options commission-free!About EUCR
Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY.
CEOParag Phoolchand Saxena, MBA
CEOParag Phoolchand Saxena, MBA
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2020
Founded2020
Employees—
Employees—
EUCR Key Statistics
Market cap42.23M
Market cap42.23M
Price-Earnings ratio53.46
Price-Earnings ratio53.46
Dividend yield—
Dividend yield—
Average volume7.18K
Average volume7.18K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.25
52 Week high$10.25
52 Week low$9.87
52 Week low$9.87
People also own
Based on the portfolios of people who own EUCR. This list is generated using Robinhood data, and it’s not a recommendation.